Citation
Publication Date:
Format:
Bibliography:
The public health impact of smoking remains as prominent as ever. At present, over 400,000 premature deaths - far and away the highest tally for any product or substance on the market - are attributable to smoking. And, per capita use and trend rates suggest no reason for relaxed regulatory scrutiny. In this article, I offer a view of past efficacy and future promise of tobacco control strategies. After a brief treatment of the demographics of smoking, indicating the distance that has been covered in reducing tobacco use, I discuss the main factors contributing to that partial success story; in particular, informational initiatives, clean air regulations, and taxation. Then, I address the strategies that, to my mind, have been somewhat less successful: litigation and advertising controls. Finally, I comment on the array of public health initiatives that might sensibly be considered at this point in time, with particular emphasis on reducing the prevalence of youth smoking.
Other publications by this author
- The Vaccine No-Fault Act: An Overview
- Tort Law and Alternatives: Cases and Materials, 9th ed.
- The Legacy of New York Times v. Sullivan: Time for a Reassessment?
- Harms from Exposure to Toxic Substances: The Limits of Liability Law
- The Pervasive Role of Uncertainty in Tort Law: Rights and Remedies
- Tort as a Litigation Lottery: A Misconceived Metaphor
- Emotional Distress in Tort Law: Themes of Constraint
- Territorial Claims in the Domain of Accident Law: Conflicting Conceptions of Tort Preemption
- Dissembling and Disclosing: Physician Responsibility on the Frontiers of Tort Law
- The Case for Specially Compensating the Victims of Terrorist Acts: An Assessment
Author
- Robert L. Rabin
- Stanford Law School
- rrabin@stanford.edu
- 650 723.3073